Condition
Castration-Naive Prostate Cancer
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Degarelix
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Degarelix1
- Mriguided Transurethral Ultrasound Ablation Tulsa1
Active Sponsors
- Turku University Hospital1
Top Investigators
Department of Urology, University of Turku and Turku University Hospital, Turku, Finland
Related Conditions
- Localized Prostate Carcinoma1
- Intermediaterisk Prostate Cancer1
- Prostate Cancer1
- Intermediate Risk Prostate Cancer1